Trial · NCT03377803
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Application site vesicles | Skin and subcutaneous tissue disorders | VP-102 | 141 | 150 | |
| other | Application site vesicles | Skin and subcutaneous tissue disorders | Placebo | 34 | 112 | |
| other | Application site scab | Skin and subcutaneous tissue disorders | VP-102 | 85 | 150 | |
| other | Application site scab | Skin and subcutaneous tissue disorders | Placebo | 22 | 112 | |
| other | Application site pruritus | Skin and subcutaneous tissue disorders | VP-102 | 65 | 150 | |
| other | Application site pruritus | Skin and subcutaneous tissue disorders | Placebo | 37 | 112 | |
| other | Application site erythema | Skin and subcutaneous tissue disorders | VP-102 | 70 | 150 | |
| other | Application site erythema | Skin and subcutaneous tissue disorders | Placebo | 28 | 112 | |
| other | Application site dryness | Skin and subcutaneous tissue disorders | VP-102 | 39 | 150 | |
| other | Application site dryness | Skin and subcutaneous tissue disorders | Placebo | 20 | 112 | |
| other | Application site discolouration | Skin and subcutaneous tissue disorders | VP-102 | 46 | 150 | |
| other | Application site discolouration | Skin and subcutaneous tissue disorders | Placebo | 9 | 112 | |
| other | Application site erosion | Skin and subcutaneous tissue disorders | VP-102 | 12 | 150 | |
| other | Application site erosion | Skin and subcutaneous tissue disorders | Placebo | 0 | 112 | |
| other | Application site Pain | Injury, poisoning and procedural complications | VP-102 | 83 | 150 | |
| other | Application site Pain | Injury, poisoning and procedural complications | Placebo | 16 | 112 | |
| other | Application site oedema | Injury, poisoning and procedural complications | VP-102 | 8 | 150 | |
| other | Application site oedema | Injury, poisoning and procedural complications | Placebo | 4 | 112 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03377803/events